News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Features Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option? Shelley Wood April 30, 2019
Presentation ARCH 2019 Spontaneous Coronary Artery Dissection Presenter: Alan C. Braverman April 13, 2019
Presentation OPCI 2019 Optimal Duration of Antiplatelet Therapy – Does IV Imaging Make A Difference? Presenter: Roxana Mehran March 09, 2019
Presentation OPCI 2019 Show Me the Data: Evidence That Physiologic Lesion Assessment Improves Patient Outcomes Presenter: Habib Samady March 09, 2019
Presentation OPCI 2019 High Definition IVUS as a tool to optimize PCI Presenter: Akiko Maehara March 09, 2019
Presentation OPCI 2019 Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD Presenter: William F. Fearon March 09, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain? Michael O'Riordan January 11, 2019
News Daily News Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD Michael O'Riordan January 03, 2019
Podcast TCTMD Talking Points FAME 2: 3-Year Clinical and Cost-Effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease September 05, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2018 FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice Todd Neale August 26, 2018
News Daily News ‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients Michael O'Riordan August 23, 2018
News Daily News Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’ Michael O'Riordan August 21, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018